Is a complete TDOC research report available?

No complete published report is available for Teladoc Health, Inc. (TDOC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Teladoc Health, Inc. (TDOC)

NYSE: TDOC · USD

$9.18

-0.18 (-1.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TDOC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.7B
Revenue (ttm)	2.5B
Net income (ttm)	-177.4M
EPS (ttm)	-$0.99
Shares out	180.5M
Volume	8,245,248
Beta	2.10
Price target	$7.97	-13.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): -177.4M
EPS (ttm): -$0.99
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TDOC indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001477449
Company name	Teladoc Health, Inc.
Country	United States
Country code	US
Cusip	87918A105
Employees	5,600
Employees Change	100%
Employees Change Percent	1.82
Enterprise value	$1.9B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Industry PE Fwd	30.24
IPO Date	2015-07-01
Isin	US87918A1051
Last refreshed	2026-07-30
Market cap	$1.7B
Market cap category	Small-Cap
Price	$9.18
Price currency	USD
Rev Per Employee	444,550x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	8011
Symbol	TDOC
Website	https://www.teladochealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.71%
EV Sales Forward	0.76x
EV/EBITDA	9.99x
EV/FCF	7.52x
EV/Sales	0.77x
FCF yield	15.31%
P/B ratio	1.24x
P/S ratio	0.67x
PS Forward	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.5%
EBITDA Margin	7.68%
FCF margin	10.19%
Gross margin	68.97%
Gross Profit	$1.7B
Gross Profit Growth	-3.88%
Gross Profit Growth Q	-5.73%
Gross Profit Growth3 Y	-1.11%
Gross Profit Growth5 Y	9.41%
Net Income	$-177.4M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-7.33%
Profit Margin	-7.13%
Profit Per Employee	$-31,678
ROA	-3.22
Roa5y	-2.32
ROCE	-13.57
ROE	-12.99
Roe5y	-45.49
ROIC	-3.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.4%
Cagr1y	11.96%
Cagr3y	-31.25%
Cagr5y	-42.95%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth	-13.03%
FCF Growth Q	-29.31%
FCF Growth3 Y	3.53%
OCF Growth	-13.92%
OCF Growth Q	-29.28%
OCF Growth3 Y	2.45%
Revenue Growth	-2.08x
Revenue Growth Q	-3.95x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	8.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.88
Assets	$2.8B
Cash	$774.3M
Current Assets	$1.1B
Current Liabilities	$1.4B
Debt	$1B
Debt EBITDA	$5.37
Debt Equity	$0.78
Debt FCF	$4.05
Equity	$1.3B
Interest Coverage	-9.36
Liabilities	$1.4B
Long Term Assets	$1.6B
Long Term Liabilities	$66.8M
Net Cash	$-251.9M
Net Cash By Market Cap	$-15.2
Net Debt EBITDA	$1.32
Net Debt Equity	$0.19
Net Debt FCF	$0.99
Tangible Book Value	$-148.8M
Tangible Book Value Per Share	$-0.82
WACC	10.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.83
Inventory Turnover	23.07
Net Working Capital	$-11M
Quick ratio	0.72
Working Capital	$-233.4M
Working Capital Turnover	$11.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-48.37%
1Y total return	11.95%
200-day SMA	6.91
3Y total return	-67.52%
50-day SMA	8.12
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.95%
All Time High	308
All Time High Change	-97.02%
All Time High Date	2021-02-16
All Time Low	4.4
All Time Low Change	108.64%
All Time Low Date	2026-02-12
ATR	0.45
Beta	2.1
Beta1y	2.34
Beta2y	1.64
Ch YTD	31.14
High	9.49
High52	9.89
High52 Date	2026-07-16
High52ch	-7.15%
Low	9.13
Low52	4.4
Low52 Date	2026-02-12
Low52ch	108.64%
Ma50ch	13.03%
Premarket Change Percent	-0.26
Premarket Price	$9.34
Premarket Volume	3,065
Price vs 200-day SMA	32.95%
RSI	55.05
RSI Monthly	43.31
RSI Weekly	64.39
Sharpe ratio	0.41x
Sortino ratio	0.75
Total Return	-2.97%
Tr YTD	31.14
Tr1m	9.42%
Tr1w	2.92%
Tr3m	53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	24
Analyst Count Top	9
Analyst Price Target Top	$8.39
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	615,576,008x
Earnings Revenue Estimate Growth	-2.58x
Operating Income	$-145.7M
Operating margin	-5.85
Price target	$7.97
Price Target Change	$-13.18
Price Target Change Top	$-8.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	179,339,065%
Float Percent	99.35%
Shares Insiders	0.65%
Shares Institutions	81.78%
Shares Out	180,513,087
Shares Qo Q	1.06%
Shares Yo Y	2.97%
Short Float	15.65%
Short Ratio	6.25
Short Shares	15.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$196.9M
Adjusted OCF	204,365,000
Average Volume	4,275,454.9x
Bv Per Share	7.21
CAPEX	$-7.5M
Ch10y	-48.37
Ch1m	9.42
Ch1w	2.92
Ch1y	11.95
Ch3m	53
Ch3y	-67.52
Ch5y	-93.95
Ch6m	59.93
Change	-1.92%
Change From Open	-2.03
Close	9.36
Days Gap	0.11
Depreciation Amortization	198,788,000
Dollar Volume	75,691,376.6
Earnings Date	2026-07-29
Earnings Time	amc
EBIT	$-186.8M
EBITDA	$191.1M
EPS	$-0.99
F Score	3
FCF	$253.7M
FCF EV Yield	13.29x
FCF Per Share	$1.41
Financing CF	-4,062,000
Fiscal Year End	December
Founded	2,002
Goodwill	283,190,000
Income Tax	$-5.2M
Investing CF	-161,151,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	6.6
Ma150ch	39.09%
Ma20	9.27
Ma20ch	-0.96%
Net CF	94,727,000
Next Earnings Date	2026-10-28
Open	9.37
Optionable	Yes
P FCF Ratio	6.53
P FCF Ratio SBC	8.42
P OCF Ratio	6.34
P OCF Ratio SBC	8.11
Position In Range	13.89
Post Close	9.18
Postmarket Change Percent	-17.43
Postmarket Price	$7.58
Ppne	47,408,000
Pre Close	9.36
Price Date	2026-07-29
Price EBITDA	$8.67
Relative Volume	1.93x
Revenue	2,489,480,000x
SBC By Revenue	2.28x
Share Based Comp	56,819,000
Tax By Revenue	-0.21x
Tr6m	59.93%
Us State	New York
Views	213
Volume	8,245,248

Teladoc Health, Inc. (TDOC)

Coverage state: Market snapshot only — no published research

Generate the first TDOC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TDOC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TDOC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TDOC

Frequently asked questions